Controllable Drug Delivery by Na+/K+ ATPase α1 Targeting Peptide Conjugated DSPE-PEG Nanocarriers for Breast Cancer

Controllable Drug Delivery by Na+/K+ ATPase α1 Targeting Peptide Conjugated DSPE-PEG Nanocarriers for Breast Cancer

Although Epirubicin (EPI) is a commonly used anthracycline for the treatment of breast cancer in clinic, the serious side effects limit its long-term administration including myelosuppression and cardiomyopathy. Nanomedicines have been widely utilized as drug delivery vehicles to achieve precise tar...

Full description

Bibliographic Details
Main Authors: Yayan Yang BS, Qian Feng PhD, Chuanfeng Ding BS, Wei Kang PhD, Xiufeng Xiao PhD, Yongsheng Yu PhD, Qian Zhou MD
Format: Article
Language:English
Published: SAGE Publishing 2021-06-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338211027898

Similar Items

Similar Items